Global Interventional Oncology Market Report By Procedure (Tumor Embolization, Tumor Ablation), By Product (Tumor Embolization), By Application (Liver Cancer, Lung Cancer, Breast Cancer, Prostate Cancer, Kidney Cancer, Bone Metastasis, Others), By End User (Hospital, Ambulatory Care Centers, Research & Academia) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2021-2028

Name: Global Interventional Oncology Market Report
Brand: Value Market Research
SKU: Healthcare
Price: 3950.00 USD
Availability: OnlineOnly
Rating: 4.2 (80 reviews)

ID:VMR11212778

April 2021

Report Formats: Electronic (PDF), MS EXCEL

Description
Table Of Content

The global demand for Interventional Oncology Market is presumed to reach the valuation of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% during the period of 2022-2028.

Interventional oncology (abbreviated IO) is a subspecialty medical field of interventional radiology that deals with the treatment and diagnosis of different types of cancers and cancer-related problems using targeted minimally invasive procedures performed under image guidance. In interventional oncology procedures, various image-guided techniques, such as computed tomography, fluoroscopy, and ultrasound, are implemented to diagnose and treat the specific site affected by the pain or cancer. This procedure is generally performed with other cancer treatments such as surgery, chemotherapy, and radiation therapy. These procedures offer several advantages: quicker recovery, shorter hospital stays, minimal side effects, and more precise and accurate treatment than other therapeutic procedures.

Market Dynamics

The rising demand for minimally invasive therapeutics is the key driving factor for the market growth. These procedures could also be used to treat patients with other related comorbidities and in inoperable patients. The capability of minimally invasive techniques to treat cancerous cells better than alternative cancer treatments such as radiation therapy, surgeries, and systematic chemotherapy has helped the technique acquire popularity. Furthermore, healthcare professionals and patients are gradually opting for minimally invasive procedures in the field of interventional oncology due to advantages of using these techniques such as shorter hospital stay, minimal risk of infection, minimal risk of complications, cause less pain, and faster recovery time in comparison to conventional surgeries. These advantages of using minimally invasive procedures will drive market growth.

The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.

Additionally, these tools also give inclusive assessment of each application/product segment in the global market of interventional oncology.

Market Segmentation

The entire interventional oncology market has been sub-categorized into procedure, product, application and end-user. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.

By Procedure

Tumor Embolization
- Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy
- Transcatheter Arterial Chemoembolization (TACE)
- Transcatheter Arterial Embolization/Bland Embolization
Tumor Ablation
- Thermal Ablation
  - Microwave Ablation
  - Radiofrequency Ablation
  - Cryoablation
  - Others (Laser and HIFU)
- Non-Thermal Ablation
  - Irreversible Electroporation

By Product

Tumor Embolization
- Radioembolic Agents
  - SIR-Spheres
  - TheraSphere
  - QuiremSpheres
- Non-Radioactive Embolic Agents
  - Microspheres
  - Drug-eluting beads
  - Particles
- Tumor Ablation
  - Capital Ablation Devices/Generators
  - Consumables & Accessories

By Application

By End User

Hospital
Ambulatory Care Centers
Research & Academia

Regional Analysis

This section covers regional segmentation which accentuates on current and future demand for interventional oncology market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.

Global Interventional Oncology Market Share by Region (Representative Graph)

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the interventional oncology market include Boston Scientific Corporation, C. R. Bard, Inc., Medtronic plc, Cook Medical LLC, Merit Medical Systems, Inc., Profound Medical Corp, AngioDynamics, Inc., BTG plc, Terumo Corporation, HealthTronics, Inc., EDAP TMS S.A., Neuwave Medical, Inc., Sirtex Medical Limited, Trod Medical, Teleflex Incorporated, Sanarus Technologies Inc., IMBiotechnologies Ltd., MedWaves, Inc., and IceCure Medical Ltd. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY
       2.1. Highlights of Interventional Oncology Market
       2.2. Global Interventional Oncology Market Snapshot

3 . INTERVENTIONAL ONCOLOGY – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Interventional Oncology Market
       3.3. Market Restraints of Interventional Oncology Market
       3.4. Opportunities of Interventional Oncology Market
       3.5. Trends of Interventional Oncology Market
       3.6. Porter’s Five Force Analysis of Interventional Oncology Market
       3.7. Interventional Oncology Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Procedure
           3.7.2 Market Attractive Analysis by Product
           3.7.3 Market Attractive Analysis by Application
           3.7.4 Market Attractive Analysis by End User
           3.7.5 Market Attractive Analysis by Region

4 . VALUE CHAIN ANALYSIS
       4.1. Interventional Oncology Value Chain Analysis
       4.2. Interventional Oncology Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Interventional Oncology Raw Material Manufactures List
           4.2.3. Price Trend of Interventional Oncology Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend

5 IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak on Interventional Oncology Market
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Interventional Oncology Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Interventional Oncology Market Size in 2020, by Scenario
       5.5. COVID-19: Micro and Macro Factor Analysis on Interventional Oncology Market

6 . GLOBAL INTERVENTIONAL ONCOLOGY MARKET ANALYSIS BY PROCEDURE
       6.1 Overview by Procedure
       6.2 Historical Data 2015-2018
       6.3 Global Interventional Oncology Market Analysis by Procedure
       6.4 Market Analysis of Tumor Embolization by Regions
       6.6 Market Analysis of Tumor Ablation by Regions

7 . GLOBAL INTERVENTIONAL ONCOLOGY MARKET ANALYSIS BY PRODUCT
       7.1 Overview by Product
       7.2 Historical Data 2015-2018
       7.3 Global Interventional Oncology Market Analysis by Product
       7.4 Market Analysis of Tumor Embolization by Regions

8 . GLOBAL INTERVENTIONAL ONCOLOGY MARKET ANALYSIS BY APPLICATION
       8.1 Overview by Application
       8.2 Historical Data 2015-2018
       8.3 Global Interventional Oncology Market Analysis by Application
       8.4 Market Analysis of Liver Cancer by Regions
       8.5 Market Analysis of Lung Cancer by Regions
       8.6 Market Analysis of Breast Cancer by Regions
       8.7 Market Analysis of Prostate Cancer by Regions
       8.8 Market Analysis of Kidney Cancer by Regions
       8.9 Market Analysis of Bone Metastasis by Regions
       8.10. Market Analysis of Others by Regions

9 . GLOBAL INTERVENTIONAL ONCOLOGY MARKET ANALYSIS BY END USER
       9.1 Overview by End User
       9.2 Historical Data 2015-2018
       9.3 Global Interventional Oncology Market Analysis by End User
       9.4 Market Analysis of Hospital by Regions
       9.5 Market Analysis of Ambulatory Care Centers by Regions
       9.6 Market Analysis of Research & Academia by Regions

10 . GLOBAL INTERVENTIONAL ONCOLOGY MARKET ANALYSIS BY GEOGRAPHY
       10.1. Regional Outlook
       10.2. Introduction
       10.3. North America
           10.3.1. Overview and Historic Data
           10.3.2. North America Interventional Oncology Market Estimate By Market Segment
           10.3.3. North America Interventional Oncology Market Estimate By Country
           10.3.4. United State
           10.3.5. Canada
           10.3.6. Mexico
       10.4. Europe
           10.4.1. Overview and Historic Data
           10.4.2. Europe Interventional Oncology Market Estimate by Market Segment
           10.4.3. Europe Interventional Oncology Market Estimate by Country
         10.4.4. United Kingdom
           10.4.5. France
           10.4.6. Germany
           10.4.7. Italy
           10.4.8. Russia
           10.4.9. Rest Of Europe
       10.5. Asia Pacific
           10.5.1. Overview and Historic Data
           10.5.2. Asia Pacific Interventional Oncology Market Estimate by Market Segment
           10.5.3. Asia Pacific Interventional Oncology Market Estimate by Country
           10.5.4. China
           10.5.5. India
           10.5.6. Japan
           10.5.7. South Korea
           10.5.8. Australia
           10.5.9. Rest Of Asia Pacific
       10.6. Latin America
           10.6.1. Overview and Historic Data
           10.6.2. Latin America Interventional Oncology Market Estimate by Market Segment
           10.6.3. Latin America Interventional Oncology Market Estimate by Country
           10.6.4. Brazil
           10.6.5. Argentina
           10.6.6. Peru
           10.6.7. Chile
           10.6.8. Rest of Latin America
       10.7. Middle East & Africa
           10.7.1. Overview and Historic Data
           10.7.2. Middle East & Africa Interventional Oncology Market Estimate by Market Segment
           10.7.3. Middle East & Africa Interventional Oncology Market Estimate by Country
           10.7.4. Saudi Arabia
           10.7.5. UAE
           10.7.6. Israel
           10.7.7. South Africa
           10.7.8. Rest Of Middle East And Africa

11 COMPETITIVE LANDSCAPE OF THE INTERVENTIONAL ONCOLOGY COMPANIES
       11.1. Interventional Oncology Market Competition
       11.2. Partnership/Collaboration/Agreement
       11.3. Merger And Acquisitions
       11.4. New Product Launch
       11.5. Other Developments

12 COMPANY PROFILES OF INTERVENTIONAL ONCOLOGY INDUSTRY
       12.1. Company Share Analysis
       12.2. Market Concentration Rate
       12.3. Boston Scientific Corporation
           12.3.1. Company Overview
           12.3.2. Financials
           12.3.3. Products
           12.3.4. Recent Developments
       12.4. C. R. Bard, Inc.
           12.4.1. Company Overview
           12.4.2. Financials
           12.4.3. Products
           12.4.4. Recent Developments
       12.5. Medtronic plc
           12.5.1. Company Overview
           12.5.2. Financials
           12.5.3. Products
           12.5.4. Recent Developments
       12.6. Cook Medical LLC
           12.6.1. Company Overview
           12.6.2. Financials
           12.6.3. Products
           12.6.4. Recent Developments
       12.7. Merit Medical Systems, Inc.
           12.7.1. Company Overview
           12.7.2. Financials
           12.7.3. Products
           12.7.4. Recent Developments
       12.8. Profound Medical Corp.
           12.8.1. Company Overview
           12.8.2. Financials
           12.8.3. Products
           12.8.4. Recent Developments
       12.9. AngioDynamics, Inc.
           12.9.1. Company Overview
           12.9.2. Financials
           12.9.3. Products
           12.9.4. Recent Developments
       12.10. BTG plc
           12.10.1. Company Overview
           12.10.2. Financials
           12.10.3. Products
           12.10.4. Recent Developments
       12.11. Terumo Corporation
           12.11.1. Company Overview
           12.11.2. Financials
           12.11.3. Products
           12.11.4. Recent Developments
       12.12. HealthTronics, Inc.
           12.12.1. Company Overview
           12.12.2. Financials
           12.12.3. Products
           12.12.4. Recent Developments
       12.13. EDAP TMS S.A.
           12.13.1. Company Overview
           12.13.2. Financials
           12.13.3. Products
           12.13.4. Recent Developments
       12.14. Neuwave Medical, Inc.
           12.14.1. Company Overview
           12.14.2. Financials
           12.14.3. Products
           12.14.4. Recent Developments
       12.15. Sirtex Medical Limited
           12.15.1. Company Overview
           12.15.2. Financials
           12.15.3. Products
           12.15.4. Recent Developments
       12.16. Trod Medical
           12.16.1. Company Overview
           12.16.2. Financials
           12.16.3. Products
           12.16.4. Recent Developments
       12.17. Teleflex Incorporated
           12.17.1. Company Overview
           12.17.2. Financials
           12.17.3. Products
           12.17.4. Recent Developments
       12.18. Sanarus Technologies Inc.
           12.18.1. Company Overview
           12.18.2. Financials
           12.18.3. Products
           12.18.4. Recent Developments
       12.19. IMBiotechnologies Ltd.
           12.19.1. Company Overview
           12.19.2. Financials
           12.19.3. Products
           12.19.4. Recent Developments
       12.20. MedWaves, Inc.
           12.20.1. Company Overview
           12.20.2. Financials
           12.20.3. Products
           12.20.4. Recent Developments
       12.21. IceCure Medical Ltd.
           12. 21.1. Company Overview
           12. 21.2. Financials
           12. 21.3. Products
           12. 21.4. Recent Developments

*Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

LIST OF FIGURES

* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Choose your Buying Option

Single User License: $ 3950.00

Upto 10 Users License: $ 4950.00

Enterprise License: $ 8600.00

Data Pack: $ 2100.00

Buy Now

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

Buy sections of this report
Buy country level reports
Request for historical data
Request discounts available for Start-Ups & Universities

Request for Special Pricing

Objectives of Study

Define and measure the global market
Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
Analyze and identify major market trends along with the factors driving or inhibiting the market growth
Study the company profiles of the major market players with their market share
Analyze competitive developments

Why Choose Us

Client First Policy

Excellent Quality

After Sales Support

24/7 Email Support

Clients

Testimonials

" Doing business with Value Market Research was – quick, easy and accurate. We got what we expected. The team was very helpful and processes were altered for our convenience. The whole process from understanding our niche requirements to delivery to after sales was excellent. "

Vincenzo Baydar – Head Planning, Leading Food Chain, US

" Excellent work!! Working with you has been easy and direct. Your flexibility to alter the report scope and timely delivery assisted me in delivering my project proposal on time. "

Mia Tang, Director - Business Strategy, Steel Industry, Germany

" This is our second purchase and we have been obliged by the service. We appreciate the efforts put by Value Market Research in terms of understanding our needs, expanding the scope of the study, delivery and handling after sales queries. "